Washington · 2025–26 Regular Sessions · Bill
SB 6183: HIV antiviral drug coverage
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 6183 is a bill introduced in the Washington Senate on January 16, 2026. According to its official title, it concerns: Concerning coverage for HIV antiviral drugs. Primary sponsor: Marko Liias (D). It lists 12 additional sponsors. Most recent recorded action (March 14, 2026): Governor signed.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official title
AN ACT Relating to coverage for HIV antiviral drugs;
Nonpartisan staff bill reports (analyses) are available on the official bill page.
Sponsors
Sponsors by party (alphabetical): Democratic 12 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Marko Liias | Primary sponsor | Democratic | Senate | 21 |
| Jessica Bateman | Co-sponsor | Democratic | Senate | 22 |
| Annette Cleveland | Co-sponsor | Democratic | Senate | 49 |
| Manka Dhingra | Co-sponsor | Democratic | Senate | 45 |
| Paul Harris | Co-sponsor | Republican | Senate | 17 |
| Bob Hasegawa | Co-sponsor | Democratic | Senate | 11 |
| T'wina Nobles | Co-sponsor | Democratic | Senate | 28 |
| Jamie Pedersen | Co-sponsor | Democratic | Senate | 43 |
| Rebecca Saldaña | Co-sponsor | Democratic | Senate | 37 |
| Derek Stanford | Co-sponsor | Democratic | Senate | 1 |
| Yasmin Trudeau | Co-sponsor | Democratic | Senate | 27 |
| Javier Valdez | Co-sponsor | Democratic | Senate | 46 |
| Claire Wilson | Co-sponsor | Democratic | Senate | 30 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Governor signed.
- Chapter 48, 2026 Laws.
- Effective date 6/11/2026.
- Delivered to Governor.
- Speaker signed.
- President signed.
- Rules suspended. Placed on Third Reading.
- Third reading, passed; yeas, 93; nays, 1; absent, 0; excused, 4.
- Rules Committee relieved of further consideration. Placed on second reading.
- HCW - Executive action taken by committee.
- HCW - Majority; do pass.
- Referred to Rules 2 Review.
Showing 12 most recent of 21 actions. Full history